Newlink Genetics Corporation logo

Newlink Genetics Corporation Share Price Today (NASDAQ: LUMO)

Newlink Genetics Corporation share price is $0 & ₹0.00 as on 10 Dec 2024 IST

▲

-4.34

(-100%)

Market is closed - opens 7 PM, 07 Jul 2025

Bell Icon

The stock has been delisted from the stock exchange on 11 Dec 2024

View live Newlink Genetics Corporation share price in Dollar and Rupees. Guide to invest in Newlink Genetics Corporation stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Newlink Genetics Corporation, along with analyst recommendations, forecasts, and comprehensive financials.

Newlink Genetics Corporation (LUMO) Key Statistics

in dollars & INR

Previous Close
$4.34
Open
$4.33
Market Capitalization
$37.5M
Today's Volume
$390.9K
Revenue TTM
$2.2M
EBITDA
$-36.3M
Earnings Per Share (EPS)
$-4.28
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-172.83%

How to invest in Newlink Genetics Corporation Stock (LUMO) from India?

It is very easy for Indian residents to invest directly in Newlink Genetics Corporation from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Newlink Genetics Corporation stock in both Indian Rupees (INR) and US Dollars (USD). Search for Newlink Genetics Corporation or LUMO on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Newlink Genetics Corporation or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Newlink Genetics Corporation shares which would translate to null fractional shares of Newlink Genetics Corporation as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Newlink Genetics Corporation, in just a few clicks!

Global Institutional Holdings in Newlink Genetics Corporation

  • Private Advisor Group, LLC

    8.61%

  • Goldman Sachs Group Inc

    4.19%

  • Vanguard Group Inc

    2.82%

  • Renaissance Technologies Corp

    2.47%

  • Jefferies Financial Group Inc

    1.40%

  • Greenwich Wealth Management LLC

    0.88%

Analyst Recommendation on Newlink Genetics Corporation

Rating
Trend

Buy

    90%Buy

    9%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Newlink Genetics Corporation(by analysts ranked 0 to 5 stars)

LUMO Newlink Genetics Corporation Financials in INR & Dollars

Revenue
Profit
Cash Flow
Annually
Quarterly
FY18
FY19
FY20
FY21
FY22
FY23
FY23Y/Y Change
Revenue
$2.1M
↑ 34.67%
Net Income
$-34.0M
↑ 9.57%
Net Profit Margin
-1.7K%
↑ 380.14%

About Newlink Genetics Corporation

Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of products and therapies for people with rare diseases. Its primary product candidate is LUM-201, an oral growth hormone secretagogue ibutamoren, which is in Phase III clinical trial for the treatment of idiopathic pediatric growth hormone deficiency and other rare endocrine disorders. The company has a clinical collaboration with Massachusetts General Hospital to evaluate oral LUM-201 in nonalcoholic fatty liver disease. Lumos Pharma, Inc. is headquartered in Austin, Texas. As of December 12, 2024, Lumos Pharma, Inc. was taken private.
Organization
Newlink Genetics Corporation
Employees
30
CEO
Mr. Richard J. Hawkins
Industry
Health Technology

Management People of Newlink Genetics Corporation

NameTitle
Mr. Richard J. Hawkins
Founder, CEO & Chairman
Dr. John C. McKew Ph.D.
Chief Scientific Officer & President
Ms. Lori D. Lawley CPA
CFO & Principal Accounting Officer
Ms. Lisa Wells Miller
Senior Director of Investor Relations
Mr. Bradley J. Powers J.D.
Chief Compliance Officer & General Counsel
Mr. Aaron Schuchart B.B.A., CPA, M.B.A.
Chief Business Officer
Dr. Pisit Pitukcheewanont FAAP, M.D.
Chief Medical Officer
Ms. Alpa Parikh
Senior Vice President of CMC & Supply Management
Mr. Eddie L. Varnado M.B.A.
Corporate Controller

Important FAQs about investing in LUMO Stock from India :

Can Indians buy Newlink Genetics Corporation shares?

Yes, Indians can invest in the Newlink Genetics Corporation (LUMO) from India.

With INDmoney, you can buy Newlink Genetics Corporation at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Newlink Genetics Corporation at zero transaction cost.

How can I buy Newlink Genetics Corporation shares from India?

It is very easy to buy Newlink Genetics Corporation from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Newlink Genetics Corporation (LUMO) be purchased?

Yes, you can buy fractional shares of Newlink Genetics Corporation with INDmoney app.

What are the documents required to start investing in Newlink Genetics Corporation stocks?

To start investing in Newlink Genetics Corporation, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is today's market capitalisation of Newlink Genetics Corporation?

Today's market capitalisation of Newlink Genetics Corporation LUMO is 37.5M

Who is the Chief Executive Officer (CEO) of Newlink Genetics Corporation ?

Mr. Richard J. Hawkins is the current Chief Executive Officer (CEO) of Newlink Genetics Corporation.